(redirected from Montelukast sodium)
Also found in: Medical.


A drug that reduces the inflammatory response by acting as a leukotriene receptor antagonist, and is used to treat the signs and symptoms of asthma.

[monte-, of unknown origin + -lukast, leukotriene receptor antagonist suff.; see zafirlukast.]


n montelukast m
References in periodicals archive ?
During Q3 FY 2017-18, Morepen Labs achieved a major breakthrough as the United States Food and Drug Administration (USFDA) cleared its anti-asthma bulk drug Montelukast Sodium for sale in the US market.
New Delhis pharmaceuticals giant Morepen Laboratories Ltd has won the approval of the United States Food and Drug Administration (USFDA) for its bulk drug Montelukast Sodium.
His previous medications oral cetirizine 10 mg/day in morning and hydroxyzine 25 mg/day in evening along with montelukast sodium 10 mg/day along with xylometazoline nasal drops were continued.
a subsidiary of Ajanta Pharma Limited, announced today the launch of Montelukast Sodium Oral Granules (4mg), a bioequivalent generic version of SINGULAIR(R) Granules, in the US market.
8) In our study, we tested the hypothesis that treatment with a leukotriene receptor antagonist (LTRA), montelukast sodium would improve airway obstruction and clinical outcomes in acute asthma exacerbation and would subsequently decrease the duration of hospital stay.
Eosinophilic cystitis:successful long-term treatment with montelukast sodium.
She was administered montelukast sodium orally for four weeks and received complete remission.
In the Kingdom, a new line of asthma control drugs known as montelukast sodium is used to prevent asthma attacks in adults and children as young as 12 months old.
Reddya[euro](tm)s Laboratories unveils US FDA approved Montelukast Sodium Oral Granules in the US(C)2012 M2 COMMUNICATIONS http://www.
Mohammad Osman Yusuf talked about Influenza virus induced asthma and its prevention with Montelukast Sodium.
Phahmacology of Montelukast sodium (Singulair), a potent a selective leukotriene D4 receptor antag onist.